Central Wireless Inc (CWIR)

[1234zxcv]

Oxygen Therapeutics - Investment Opportunity
April 29, 2016 • 15 Likes • 3 Comments

Dear Friends,

Oxygen Therapeutics Inc. has developed an oxygen therapy drug for the treatment of hypoxia, traumatic brain Injury and stroke.

Here are the drug characteristics: Delivers oxygen immediately upon infusion ; Long shelf life at liquid form; 3 years at room temperature; Shelf life in dry form, INDEFINITELY; Universally compatible; Non immunogenic; Small molecule (1/5000th the size of a RBC); Low viscosity; In mammals, tissue oxygenation.

The product was approved by the FDA for the treatment of Anemia in dogs!

At present, we have put forth an in-house fund raising campaign to offer all friends, shareholders, past and present, an opportunity to participate in the development of Oxygen Therapeutics, Inc.

We are raising money as a private company in $5000 units. We have just begun the process of going public through a Regulation A Plus and expect to be public in less than six months. This is pre-IPO money we are raising, hence the great deal you are getting. I’ll be happy to set up a conference call per request.

If you have any questions and want to get involved in helping our effort to raise money for the company please send us an email.

[e-mail]

[e-mail]

Thank you in advance for your participation.

Sincerely,

David

Written by

David Platt
David Platt
CEO & Chairman at Oxygen Therapy, Inc.
3 comments
Sign in to leave your